An early therapeutic attempt was made by generating a recombinant strain of Salmonella typhimurium expressing CCL22-miRNA that was able to suppress a Th2 proinflammatory chemokine (CCL22) which is often involved in AD pathogenesis. This evidence concerns the gene CCL22 and Alzheimer disease.